Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient mice-Reference-Cited by-同舟云学术

Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient mice

Published:2019-01-30 Issue:3-4 Volume:26 Page:121-130
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Leggiero Eleonora,Labruna Giuseppe,Iaffaldano Laura,Lombardo Barbara,Greco Adelaide,Fiorenza Dario,Gramanzini Matteo,Montanaro Donatella,Baldi Alfonso,Cerullo Vincenzo^ORCID,Sacchetti Lucia,Pastore Lucio^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/s41434-019-0061-z.pdf

Reference45 articles.

1. Teramoto T, Shirakawa M, Kikuchi M, Nakagomi M, Tamura S, Surks HK, et al. Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with dyslipidemia. Atherosclerosis. 2013;230:52–60.

2. Vallejo-Vaz AJ, Kondapally Seshasai SR, Cole D, Hovingh GK, Kastelein JJ, et al. Familial hypercholesterolaemia: a global call to arms. Atherosclerosis. 2015;243:257–9.

3. Sniderman AD, Tsimikas S, Fazio S. The severe hypercholesterolemia phenotype: clinical diagnosis, management, and emerging therapies. J Am Coll Cardiol. 2014;63:1935–47.

4. Thomas GS, Cromwell WC, Ali S, Flaim JD, Davidson M. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol. 2013;62:2178–84.

5. Tada H, Kawashiri MA, Yoshida T, Teramoto R, Nohara A, Konno T, et al. Lipoprotein(a) in familial hypercholesterolemia with proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutations. Circ J. 2016;80:512–8.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New opportunities in the management and treatment of refractory hypercholesterolemia using in vivo CRISPR-mediated genome/base editing;Nutrition, Metabolism and Cardiovascular Diseases;2023-12

2. A Review of Progress on Targeting LDL Receptor-Dependent and -Independent Pathways for the Treatment of Hypercholesterolemia, a Major Risk Factor of ASCVD;Cells;2023-06-16

3. Gene transfer and genome editing for familial hypercholesterolemia;Frontiers in Molecular Medicine;2023-04-03

4. Gene and cell therapy approaches for familial hypercholesterolemia: An update;Drug Discovery Today;2023-03

5. The Progression of Treatment for Refractory Hypercholesterolemia: Focus on the Prospect of Gene Therapy;Frontiers in Genetics;2022-06-09